PAR-2 activation, PGE2, and COX-2 in human asthmatic and nonasthmatic airway smooth muscle cells

被引:68
作者
Chambers, LS [1 ]
Black, JL [1 ]
Ge, Q [1 ]
Carlin, SM [1 ]
Au, WW [1 ]
Poniris, M [1 ]
Thompson, J [1 ]
Johnson, PR [1 ]
Burgess, JK [1 ]
机构
[1] Univ Sydney, Dept Pharmacol, Sydney, NSW 2006, Australia
关键词
protease-activated receptor; tryptase; asthma; prostaglandin E-2; cyclooxygenase-2;
D O I
10.1152/ajplung.00416.2002
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The protease-activated receptor-2 (PAR-2) is present on human airway smooth muscle (ASM) cells and can be activated by mast cell tryptase, trypsin, or an activating peptide (AP). Trypsin induced significant increases in PGE(2) release from human ASM cells after 6 and 24 h and also induced cyclooxygenase (COX)-2 mRNA expression and COX-2 protein. Tryptase and the PAR-2 AP did not alter PGE(2) release or COX-2 protein levels, suggesting a lack of PAR-2 involvement. When we compared results in asthmatic and nonasthmatic muscle cells, both trypsin and bradykinin induced less PGE(2) from asthmatic ASM cells, and bradykinin induced significantly less COX-2 mRNA in asthmatic cells. Significantly less PGE(2) was released from proliferating ASM cells from asthmatic patients. In conclusion, trypsin induces PGE(2) release and COX-2 in human ASM cells, which is unlikely to be via PAR-2 activation. In addition, ASM cells from asthmatic patients produce significantly less PGE(2) and COX-2 compared with nonasthmatic cells. These findings may contribute to the increase in muscle mass evident in asthmatic airways.
引用
收藏
页码:L619 / L627
页数:9
相关论文
共 35 条
[1]   Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells [J].
Asokananthan, N ;
Graham, PT ;
Fink, J ;
Knight, DA ;
Bakker, AJ ;
McWilliam, AS ;
Thompson, PJ ;
Stewart, GA .
JOURNAL OF IMMUNOLOGY, 2002, 168 (07) :3577-3585
[2]   COX-2 and cytosolic PLA2 mediate IL-1β-induced cAMP production in human vascular smooth muscle cells [J].
Beasley, D .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1999, 276 (04) :H1369-H1378
[3]   Expression of cyclo-oxygenase-2 in human airway smooth muscle is associated with profound reductions in cell growth [J].
Belvisi, MG ;
Saunders, M ;
Yacoub, M ;
Mitchell, JA .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (05) :1102-1108
[4]   Induction of cyclo-oxygenase-2 by cytokines in human cultured airway smooth muscle cells: Novel inflammatory role of this cell type [J].
Belvisi, MG ;
Saunders, MA ;
Haddad, EB ;
Hirst, SJ ;
Yacoub, MH ;
Barnes, PJ ;
Mitchell, JA .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 (05) :910-916
[5]   Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells [J].
Berger, P ;
Perng, DW ;
Thabrew, H ;
Compton, SJ ;
Cairns, JA ;
McEuen, AR ;
Marthan, R ;
De Lara, JMT ;
Walls, AF .
JOURNAL OF APPLIED PHYSIOLOGY, 2001, 91 (03) :1372-1379
[6]   Induction of vascular smooth muscle cell growth by selective activation of the proteinase activated receptor-2 (PAR-2) [J].
Bono, F ;
Lamarche, I ;
Herbert, JM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 241 (03) :762-764
[7]   Tryptase's potent mitogenic effects in human airway smooth muscle cells are via nonproteolytic actions [J].
Brown, JK ;
Jones, CA ;
Rooney, LA ;
Caughey, GH ;
Hall, IP .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2002, 282 (02) :L197-L206
[8]   FUNCTIONAL-CHARACTERISTICS OF BRONCHIAL EPITHELIUM OBTAINED BY BRUSHING FROM ASTHMATIC AND NORMAL SUBJECTS [J].
CAMPBELL, AM ;
CHANEZ, P ;
VIGNOLA, AM ;
BOUSQUET, J ;
COURET, I ;
MICHEL, FB ;
GODARD, P .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (03) :529-534
[9]   Functional effects of protease-activated receptor-2 stimulation on human airway smooth muscle [J].
Chambers, LS ;
Black, JL ;
Poronnik, P ;
Johnson, PRA .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2001, 281 (06) :L1369-L1378
[10]   Protease-activated receptor-2 (PAR2) in the airways [J].
Cocks, TM ;
Moffatt, JD .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2001, 14 (03) :183-191